Comparison of the Effect of Supplementation of Garlic and Ginger on Delayed Onset Muscle Soreness and Muscular Damage

Comparison of the Effect of Short-Term Supplementation of Garlic and Ginger on Delayed Onset Muscle Soreness and Muscular Damage Induced by a Progressive Resistance Training Session in Inactive Middle-Aged Women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230805059042N1

Enrollment

Registered

2023-09-07

Start date

2023-08-12

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed contusion and muscle damage.

Interventions

Intervention 1: The first intervention group: the ginger supplement group that consumes 2 capsules of 500 mg of Gol Daru ginger manufacturing plant daily in 2 meals with 250 ml of water. Intervention

Eligibility

Sex/Gender

Female

Age

35 Years to 55 Years

Inclusion criteria

Inclusion criteria: Healthy inactive middle-aged women with an age range of 35 to 55 years Having a BMI in the range of 26 to 30

Exclusion criteria

Exclusion criteria: Suffering from various diseases or musculoskeletal injuries Suffering from specific and underlying diseases (Diabetes, Cardiovascular diseases, Endocrine diseases, Blood pressure disorders (Hypertension or Hypotension), etc.) Smoking or alcohol consumption Use of anti-inflammatory, steroid and non-steroidal drugs for at least 2 months before Use of any antioxidant supplements in the 6 months prior to the start of the study Any sensitivity or allergy to research supplements History of regular physical activity or sports in the six months before the start of the research

Design outcomes

Primary

Measure	Time frame
Lactate dehydrogenase level. Timepoint: Before the intervention and 14 days after the intervention (at each turn, immediately after training). Method of measurement: Blood sampling from the pre-elbow vein after the training session.;Creatine kinase level. Timepoint: Before the intervention and 14 days after the intervention (at each turn, immediately after training). Method of measurement: Blood sampling from the pre-elbow vein after the training session.	—

Measure

Time frame

Lactate dehydrogenase level. Timepoint: Before the intervention and 14 days after the intervention (at each turn, immediately after training). Method of measurement: Blood sampling from the pre-elbow vein after the training session.;Creatine kinase level. Timepoint: Before the intervention and 14 days after the intervention (at each turn, immediately after training). Method of measurement: Blood sampling from the pre-elbow vein after the training session.

—

Secondary

Measure	Time frame
Circumference around the thigh. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Tape measure.;Knee joint range of motion. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Goniometer.;Perception of muscle pain. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Visual Analog Scale Questionnaire.	—

Measure

Time frame

Circumference around the thigh. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Tape measure.;Knee joint range of motion. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Goniometer.;Perception of muscle pain. Timepoint: Before the intervention and 14 days after the intervention(At any time, immediately and 24 hours after training). Method of measurement: Visual Analog Scale Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahya Hodaei

Islamic Azad University

mahya.hodaei@gmail.com+98 11 5423 7182

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026